PPC
PFE icon

Park Place Capital’s Pfizer PFE Stock Holding History

Park Place Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$618K Sell
22,001
-4,712
-18% -$125K 0.12% 105
2025
Q4 		$665K Sell
26,713
-37,733
-59% -$952K 0.14% 102
2025
Q3 		$1.64M Buy
64,446
+7,763
+14% +$192K 0.35% 50
2025
Q2 		$1.42M Buy
56,683
+43,479
+329% +$1.01M 0.32% 59
2025
Q1 		$335K Buy
13,204
+5,616
+74% +$147K 0.09% 142
2024
Q4 		$201K Sell
7,588
-4,430
-37% -$120K 0.06% 197
2024
Q3 		$348K Sell
12,018
-2,201
-15% -$64.2K 0.1% 163
2024
Q2 		$398K Sell
14,219
-4,351
-23% -$120K 0.13% 152
2024
Q1 		$515K Buy
18,570
+756
+4% +$21K 0.18% 134
2023
Q4 		$513K Sell
17,814
-3,169
-15% -$95.8K 0.2% 134
2023
Q3 		$696K Sell
20,983
-425
-2% -$15K 0.2% 122
2023
Q2 		$785K Buy
21,408
+693
+3% +$27K 0.22% 112
2023
Q1 		$845K Buy
20,715
+3,504
+20% +$151K 0.24% 97
2022
Q4 		$882K Buy
+17,211
New +$825K 0.25% 94

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Park Place Capital's PFE Position: Q1 2026 in Review

Park Place Capital reduced its Pfizer (PFE) stake by 18% in Q1 2026, selling an estimated $125K and leaving 22,001 shares worth $618K. The position accounts for 0.12% of the portfolio, ranked #105.

Park Place Capital first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.64M in Q3 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Park Place Capital held 22,001 shares of Pfizer worth $618K as of Q1 2026.
  • Park Place Capital sold 4,712 Pfizer shares in Q1 2026, an estimated $125K.
  • Pfizer made up 0.12% of Park Place Capital's portfolio in Q1 2026, its #105 holding.
  • Park Place Capital first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Pfizer position peaked at $1.64M in Q3 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.